For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Achaogen, Inc.

USPTO Granted Patents = 22

% Expired Patents = 50.0

CIPO Patents = 2

EPO Patents = 2

Forward Citations = 125

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

James Bradley Aggen (18 out of 51 patents)

Martin Sheringham Linsell (18 out of 82 patents)

Paola Dozzo (18 out of 19 patents)

4. Adam Aaron Goldblum (16 out of 47 patents)

5. Darin James Hildebrandt (12 out of 13 patents)

6. Micah James Gliedt (12 out of 17 patents)

7. Heinz Ernst Moser (8 out of 17 patents)

8. Timothy Robert Kane (8 out of 8 patents)

9. Brian D Patterson (3 out of 3 patents)

10. Qing Lu (3 out of 13 patents)

11. Ramesh Annasaheb Kasar (3 out of 3 patents)

12. Ryan Cirz (2 out of 3 patents)

13. Frederick Cohen (2 out of 29 patents)

14. Glenn McEnroe (2 out of 7 patents)

15. Stephen W Kaldor (1 out of 68 patents)

22 patents: Sort by Forward Citations

1. 10624899 - Combination products for the treatment of bacterial infections and methods of producing or dosing of same (2020-04-21),

2. RE47741 - Antibacterial aminoglycoside analogs (2019-11-25),

3. 9701622 - Antibacterial agents (2017-07-11),

4. 9688711 - Antibacterial aminoglycoside analogs (2017-06-27),

5. 9617256 - Antibacterial agents (2017-04-11),

6. 9403758 - Antibacterial agents (2016-08-02),

7. 9266919 - Antibacterial aminoglycoside analogs (2016-02-23),

8. 8822424 - Antibacterial aminoglycoside analogs (2014-09-02),

9. 8658606 - Antibacterial aminoglycoside analogs (2014-02-25),

10. 8653042 - Antibacterial aminoglycoside analogs (2014-02-18),

11. 8653041 - Antibacterial aminoglycoside analogs (2014-02-18),

12. 8524689 - Antibacterial aminoglycoside analogs (2013-09-03),

13. 8524675 - Antibacterial aminoglycoside analogs (2013-09-03),

14. 8492354 - Antibacterial aminoglycoside analogs (2013-07-23),

15. 8481502 - Antibacterial aminoglycoside analogs (2013-07-09),

Achaogen, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative antibacterial treatments for multi-drug resistant infections. With a mission to save lives threatened by antibiotic-resistant pathogens, Achaogen uses its expertise in gram-negative bacteria and synthetic chemistry to create novel therapeutic options. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

22 Patents

#58 in South San Francisco, CA

#3,579 in California

#15,000 in US

#28,686 in the World

South San Francisco, CA, United States of America

Achaogen, Inc.

Forward Citations = 125

30 inventors:

James Bradley Aggen (18 out of 51 patents)

Martin Sheringham Linsell (18 out of 82 patents)

Paola Dozzo (18 out of 19 patents)

4. Adam Aaron Goldblum (16 out of 47 patents)

5. Darin James Hildebrandt (12 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…